Capsule Endoscopy for Portal Hypertensive Enteropathy
Portal hypertensive enteropathy (PHE) is a mucosal abnormality of the small bowel that is observed in patients with portal hypertension (PH) and can lead to gastrointestinal bleeding and anemia. The pathogenesis is still not completely understood. The introduction of new endoscopic methods, includin...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2016/8501394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832545358977171456 |
|---|---|
| author | Seong Ran Jeon Jin-Oh Kim |
| author_facet | Seong Ran Jeon Jin-Oh Kim |
| author_sort | Seong Ran Jeon |
| collection | DOAJ |
| description | Portal hypertensive enteropathy (PHE) is a mucosal abnormality of the small bowel that is observed in patients with portal hypertension (PH) and can lead to gastrointestinal bleeding and anemia. The pathogenesis is still not completely understood. The introduction of new endoscopic methods, including capsule endoscopy (CE) or balloon-assisted enteroscopy, has increased the detection of these abnormalities. CE can also serve as a road map for deciding subsequent interventions and evaluating the treatment effect. The prevalence of PHE is reportedly 40–70% in patients with PH. Endoscopic findings can be roughly divided into vascular and nonvascular lesions such as inflammatory-like lesions. Traditionally, PHE-associated factors include large esophageal varices, portal hypertensive gastropathy or colopathy, Child-Turcotte-Pugh class B or C, a history of variceal treatment, and acute gastrointestinal bleeding. More recently, on using scoring systems, a high computed tomography or transient elastography score was reportedly PHE-related factors. However, the prevalence of PHE and its related associated factors remain controversial. The management of PHE has not yet been standardized. It should be individualized according to each patient’s situation, the availability of therapy, and each institutional expertise. |
| format | Article |
| id | doaj-art-3b3224063eeb4b579edf3130781091bf |
| institution | Kabale University |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-3b3224063eeb4b579edf3130781091bf2025-02-03T07:25:59ZengWileyGastroenterology Research and Practice1687-61211687-630X2016-01-01201610.1155/2016/85013948501394Capsule Endoscopy for Portal Hypertensive EnteropathySeong Ran Jeon0Jin-Oh Kim1Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Republic of KoreaInstitute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Republic of KoreaPortal hypertensive enteropathy (PHE) is a mucosal abnormality of the small bowel that is observed in patients with portal hypertension (PH) and can lead to gastrointestinal bleeding and anemia. The pathogenesis is still not completely understood. The introduction of new endoscopic methods, including capsule endoscopy (CE) or balloon-assisted enteroscopy, has increased the detection of these abnormalities. CE can also serve as a road map for deciding subsequent interventions and evaluating the treatment effect. The prevalence of PHE is reportedly 40–70% in patients with PH. Endoscopic findings can be roughly divided into vascular and nonvascular lesions such as inflammatory-like lesions. Traditionally, PHE-associated factors include large esophageal varices, portal hypertensive gastropathy or colopathy, Child-Turcotte-Pugh class B or C, a history of variceal treatment, and acute gastrointestinal bleeding. More recently, on using scoring systems, a high computed tomography or transient elastography score was reportedly PHE-related factors. However, the prevalence of PHE and its related associated factors remain controversial. The management of PHE has not yet been standardized. It should be individualized according to each patient’s situation, the availability of therapy, and each institutional expertise.http://dx.doi.org/10.1155/2016/8501394 |
| spellingShingle | Seong Ran Jeon Jin-Oh Kim Capsule Endoscopy for Portal Hypertensive Enteropathy Gastroenterology Research and Practice |
| title | Capsule Endoscopy for Portal Hypertensive Enteropathy |
| title_full | Capsule Endoscopy for Portal Hypertensive Enteropathy |
| title_fullStr | Capsule Endoscopy for Portal Hypertensive Enteropathy |
| title_full_unstemmed | Capsule Endoscopy for Portal Hypertensive Enteropathy |
| title_short | Capsule Endoscopy for Portal Hypertensive Enteropathy |
| title_sort | capsule endoscopy for portal hypertensive enteropathy |
| url | http://dx.doi.org/10.1155/2016/8501394 |
| work_keys_str_mv | AT seongranjeon capsuleendoscopyforportalhypertensiveenteropathy AT jinohkim capsuleendoscopyforportalhypertensiveenteropathy |